Events

  Deconstructing Regenerative Medicine: from cells to exosomes and defined factors Eduardo Marbán, MD, PhD Executive Director Smidt Heart Institute Cedars-Sinai Medical Center Wednesday, February 19, 2020 1:00 – 2:00 pm NTT 7409 Eduardo Marbán, MD, PhD, is a pioneering physician-scientist whose key discoveries in gene- and cell-based therapies have formed the basis for three…

  Amgen Research & Development and Careers in Science Kristin Fischer Director, Human Resources Amgen Global Research Monday, September 23, 2019 2:00 – 3:00 pm NRT LG 503/504 Kristin Fischer is currently the head of Human Resources for Amgen Global Research. Kristin joined Amgen in 2004 and has held HR leadership roles within Amgen’s operations in…

    Lab Rat to CEO: Lessons from Paddling in the Shark Tank Andrew Gray, PhD Co-founder, CEO Karma Biotechnologies Thursday, September 19, 2019 12:00 – 1:00 pm NRT 2508 Dr. Andrew Gray is an immune engineer and entrepreneur on a mission to bring treatments for autoimmunity into the 21st century. He is the cofounder…

  Emily Leproust, PhD CEO, co-founder Twist Bioscience Monday, August 19, 2019 12:00 – 1:00 pm NRT LG503/504, HSC Join us for lunch to learn about Twist’s cutting-edge DNA synthesis technology and how Twist Synthetic Biology and NGS Target Enrichment Solutions can help you elevate your research discoveries. Boxed lunches provided by Twist Bioscience. seminar…

  USC Translational Genomics Symposium   Wednesday, May 29, 2019 8:00 am – 5:00 pm Aresty Auditorium     See what NGS can do for your research Over 100 participants joined us for a unique opportunity where we brought together speakers from across the academic, clinical, and biotechnology spectrum to discuss how they are using…

  From Research in a Bio Lab to Founder of a Startup Albert Hsieh, PhD Founder Genpedia Wednesday, April 24, 2019 1:00 – 2:00 pm NRT 2508   Dr. Hsieh is passionate to develop precision diagnostics tools to improve human’s health in the past 20 years. He is currently the founder of Genpedia. Genpedia’s mission…

  Process Development of Biologic and Synthetic Therapeutics Kathryn Abele Henckels, PhD Secnior Scientist Process Development Amgen Wednesday, April 10, 2019 1:00 – 2:00 pm NRT 2508 Kathryn Henckels is a Senior Scientist in Process Development at Amgen where she leads a team focused on establishing cell therapy capabilities. Kathryn received her PhD in Biological…

  Early Stage Healthcare Investing in LA Kwame Ulmer Venture Partner Wavemaker Three-Sixty Health Wednesday, April 3, 2019 1:00 – 2:00 pm NRT 2508 Kwame Ulmer is a venture partner at Wavemaker Three-Sixty Health – the leading Southern-California based, early stage venture capital firm (Seed and Series A) focused on the healthcare industry.  He participates…

  Early Phase Drug Development: Novel Methods to De-risk CNS Compounds Brett A. English, PhD Director, Clinical Development Arena Pharmaceuticals Wednesday, March 27, 2019 1:00 – 2:00 pm NRT 2508 Dr. English is a pharmacist and pharmaceutical scientist with many years of experience in several different areas of the field. After completing his PharmD at…

  A Talk with Principal at DeciBio to Find Out – how biotech consultant works – how to become one Andrew Aijian, PhD Principal, DeciBio Wednesday, February 27, 2019 1:00 – 2:00 pm NRT 2508 Andrew Aijian is a life sciences professional engaged in strategy development and market analysis for the life science research, diagnostic,…